Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

Abstract The objectives of our study were to assess retention rate, safety, and predictive factors for retention of subcutaneous (SC) TNF inhibitors (TNFi) (adalimumab (ADA), etanercept (ETN), golimumab (GOL), and certolizumab pegol (CZP)) in axial spondyloarthritis (axSpA) depending on the line of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Guillaume Larid, Guy Baudens, Georges Tiemdjo-Djimaffo, Pascal Coquerelle, Vincent Goeb, Marie Hélène Guyot, Laurent Marguerie, Frédéric Maury, Eric Veillard, Eric Houvenagel, Jean-Hugues Salmon, René-Marc Flipo, Elisabeth Gervais
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2024-01-01
Edice:	Scientific Reports
On-line přístup:	https://doi.org/10.1038/s41598-024-52016-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!